Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis (Q34362340)

1 August 2017

0 references

Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis (English)

1 reference

1 August 2017

0 references

1

Amirhossein Sahebkar

1 reference

1 August 2017

publication date

7 August 2013

1 reference

1 August 2017

published in

Phytotherapy Research

1 reference

1 August 2017

volume

28

1 reference

1 August 2017

issue

5

1 reference

1 August 2017

page(s)

633-642

1 reference

Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals

1 August 2017

cites work

1 reference

Bioavailability of curcumin: problems and promises

21 January 2018

1 reference

Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease

21 January 2018

1 reference

High-dose curcuminoids are efficacious in the reduction in symptoms and signs of oral lichen planus

21 January 2018

1 reference

Curcumin and its analogues as potent inhibitors of low density lipoprotein oxidation: H-atom abstraction from the phenolic groups and possible involvement of the 4-hydroxy-3-methoxyphenyl groups

21 January 2018

1 reference

Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation

21 January 2018

1 reference

Protective effects of nanoparticulate coenzyme Q10 and curcumin on inflammatory markers and lipid metabolism in streptozotocin-induced diabetic rats: a possible remedy to diabetic complications.

21 January 2018

1 reference

Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people

21 January 2018

1 reference

Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies.

21 January 2018

1 reference

Macrophage uptake of low-density lipoprotein bound to aggregated C-reactive protein: possible mechanism of foam-cell formation in atherosclerotic lesions

21 January 2018

1 reference

Structure and function of the pentraxins

21 January 2018

1 reference

Efficacy and safety of ABT-335 (fenofibric acid) in combination with atorvastatin in patients with mixed dyslipidemia

21 January 2018

1 reference

Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers

21 January 2018

1 reference

Effects of peroxisome proliferator-activated receptor ligands, bezafibrate and fenofibrate, on adiponectin level

21 January 2018

1 reference

Curcumin therapy in inflammatory bowel disease: a pilot study

21 January 2018

1 reference

Estimating the mean and variance from the median, range, and the size of a sample

21 January 2018

1 reference

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

Efficacy and safety of ABT-335 (fenofibric acid) in combination with rosuvastatin in patients with mixed dyslipidemia: a phase 3 study

21 January 2018

1 reference

Therapeutic options to further lower C-reactive protein for patients on statin treatment

21 January 2018

1 reference

Simvastatin with or without ezetimibe in familial hypercholesterolemia

21 January 2018

1 reference

The complement system in myocardial ischaemia/reperfusion injury

21 January 2018

1 reference

C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon?

21 January 2018

1 reference

Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine

21 January 2018

1 reference

Antioxidant and anti-inflammatory properties of curcumin

21 January 2018

1 reference

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction

21 January 2018

1 reference

Influence of red pepper spice and turmeric on inflammation and oxidative stress biomarkers in overweight females: a metabolomics approach

21 January 2018

1 reference

Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: results of a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

A randomized controlled trial on the anti-inflammatory effects of curcumin in patients with chronic sulphur mustard-induced cutaneous complications

21 January 2018

1 reference

C-reactive protein (CRP)-lowering agents

21 January 2018

1 reference

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

21 January 2018

1 reference

C-reactive protein levels and outcomes after statin therapy

21 January 2018

1 reference

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

Molecular mechanisms for curcumin benefits against ischemic injury

21 January 2018

1 reference

Curcuminoids modulate pro-oxidant-antioxidant balance but not the immune response to heat shock protein 27 and oxidized LDL in obese individuals

21 January 2018

1 reference

Curcuma as a functional food in the control of cancer and inflammation

21 January 2018

1 reference

Curcumin in Cancer Chemoprevention: Molecular Targets, Pharmacokinetics, Bioavailability, and Clinical Trials

21 January 2018

1 reference

New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases

21 January 2018

1 reference

Curcumin in inflammatory diseases

21 January 2018

1 reference

Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma

21 January 2018

1 reference

Influence of Piperine on the Pharmacokinetics of Curcumin in Animals and Human Volunteers

21 January 2018

1 reference

Effect of exclusion diet with nutraceutical therapy in juvenile Crohn's disease

21 January 2018

1 reference

Currying the heart: curcumin and cardioprotection

21 January 2018

1 reference

Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials

21 January 2018

1 reference

Cardioprotective effect of curcumin against doxorubicin-induced myocardial toxicity in albino rats

21 January 2018

1 reference

Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with sta

21 January 2018

1 reference

Pathophysiology of atherosclerosis: the role of inflammation

21 January 2018

1 reference

The liver as the site of C-reactive protein formation

21 January 2018

1 reference

The protective role of curcumin in cardiovascular diseases

21 January 2018

1 reference

Effects of curcuminoids on frequency of acute myocardial infarction after coronary artery bypass grafting.

21 January 2018

1 reference

Inhibition of NFkappaB activation with curcumin attenuates plasma inflammatory cytokines surge and cardiomyocytic apoptosis following cardiac ischemia/reperfusion

21 January 2018

1 reference

High-sensitivity C-reactive protein and atherosclerosis: from theory to therapy

21 January 2018

1 reference

The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina

21 January 2018

1 reference

Curcumin prevents and reverses murine cardiac hypertrophy

21 January 2018

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1172/JCI32865

Identifiers

DOI

10.1002/PTR.5045

1 reference

1 August 2017

1 reference